ER (Estrogen Receptor)
27 drugsPredictive biomarker for patient selection in 16 indications
27
Approved Drugs
16
Indications
22
Companies
ER (Estrogen Receptor) is a precision-medicine biomarker linked to 27 FDA-approved targeted drugs from 22 companies, spanning 16 indications including Vasomotor Symptoms, Vulvar and Vaginal Atrophy, Osteoporosis. Explore the targeted therapies, indications, testing methods, and companies developing ER (Estrogen Receptor) drugs below.
Search ER (Estrogen Receptor) Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting ER (Estrogen Receptor)
| Drug | Company | Therapeutic Area |
|---|---|---|
| ACTIVELLA | Novo Nordisk | Women's Health |
| ANGELIQ | Bayer | Women's Health |
| BIJUVA | MAYNE PHARMA | Women's Health |
| CLIMARA | Bayer | Women's Health |
| CLIMARA PRO | BERLEX LABS | Women's Health |
| CONJUGATED ESTROGENS | NOVAST LABS LTD | Oncology |
| DIVIGEL | VERTICAL PHARMS | Women's Health |
| ELESTRIN | Viatris | Women's Health |
| ESTRADIOL AND NORETHINDRONE ACETATE | Teva | Women's Health |
| ESTROGEL | ASCEND THERAPS US | Women's Health |
| EVAMIST | PADAGIS US | Women's Health |
| EVISTA | Eli Lilly | Oncology |
| FASLODEX | AstraZeneca | Oncology |
| FEMRING | MILLICENT MFG PR | Women's Health |
| FULVESTRANT | EUGIA PHARMA | Oncology |
| FYAVOLV | Lupin | Women's Health |
| IMVEXXY | MAYNE PHARMA | Women's Health |
| MENOSTAR | Bayer | Women's Health |
| MINIVELLE | NOVEN | Women's Health |
| MYFEMBREE | SUMITOMO PHARMA AM | Women's Health |
| OSPHENA | DUCHESNAY | Women's Health |
| PREMPHASE 14/14 | Pfizer | Oncology |
| PREMPRO | Pfizer | Women's Health |
| RALOXIFENE HYDROCHLORIDE | Teva | Oncology |
| SOLTAMOX | MAYNE PHARMA COMMRCL | Oncology |
| TOREMIFENE CITRATE | RISING | Oncology |
| VIVELLE-DOT | Novartis | Women's Health |
ER (Estrogen Receptor) Indications
Vasomotor Symptoms Vulvar and Vaginal Atrophy Osteoporosis Breast Cancer Metastatic Breast Cancer Ductal Carcinoma in Situ Dyspareunia Vaginal Dryness Hypoestrogenism Prostate Cancer Heavy Menstrual Bleeding Uterine Leiomyoma Endometriosis Hypogonadism Primary Ovarian Failure Postmenopausal Osteoporosis